do-me/EUR-LEX huggingface dataset:
Non-opposition to a notified concentration (Case M.7821 — Ardian France/Solina) (Text with EEA relevance)
Date: 2015-11-28
Institutions: European Commission
Subjects: economic concentration, flavouring, food industry, holding company, investment company, merger control








C_2015397EN.01000101.xml










28.11.2015   


EN


Official Journal of the European Union


C 397/1





Non-opposition to a notified concentration
(Case M.7821 — Ardian France/Solina)
(Text with EEA relevance)
(2015/C 397/01)
On 24 November 2015, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English language and will be made public after it is cleared of any business secrets it may contain. It will be available:






—


in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,










—


in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32015M7821. EUR-Lex is the online access to the European law.






(1)  OJ L 24, 29.1.2004, p. 1.
Prior notification of a concentration (Case M.7872 — Novartis/GSK (Ofatumumab Autoimmune Indications)) (Text with EEA relevance)
Date: 2015-11-28
Institutions: European Commission
Subjects: economic concentration, health care, merger control, pharmaceutical industry








C_2015397EN.01002001.xml










28.11.2015   


EN


Official Journal of the European Union


C 397/20





Prior notification of a concentration
(Case M.7872 — Novartis/GSK (Ofatumumab Autoimmune Indications))
(Text with EEA relevance)
(2015/C 397/06)






1.


On 18 November 2015, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which Novartis AG (‘Novartis’, Switzerland) acquires from GlaxoSmithKline plc (‘GSK’, United Kingdom), within the meaning of Article 3(1)(b) of the Merger Regulation, sole control of the rights to the autoimmune indications with respect to the pharmaceutical Ofatumumab, by way of purchase of assets.










2.


The business activities of the undertakings concerned are:






—


Novartis is a Swiss healthcare company, active worldwide in three broad areas of healthcare: pharmaceuticals, eye care and generics,










—


GSK is a British pharmaceutical company active worldwide in the areas of pharmaceuticals, vaccines and consumer health products.














3.


On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.










4.


The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number M.7872 — Novartis/GSK (Ofatumumab Autoimmune Indications), to the following address:





European Commission




Directorate-General for Competition




Merger Registry




1049 Bruxelles/Brussel




BELGIQUE/BELGIË










(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
Euro exchange rates
Date: 2015-11-28
Institutions: European Commission
Subjects: euro, exchange rate








C_2015397EN.01000901.xml










28.11.2015   


EN


Official Journal of the European Union


C 397/9





Euro exchange rates (1)

27 November 2015
(2015/C 397/04)

1 euro =











 


Currency


Exchange rate




USD


US dollar


1,0580




JPY


Japanese yen


129,75




DKK


Danish krone


7,4605




GBP


Pound sterling


0,70290




SEK


Swedish krona


9,2420




CHF


Swiss franc


1,0900




ISK


Iceland króna


 




NOK


Norwegian krone


9,1885




BGN


Bulgarian lev


1,9558




CZK


Czech koruna


27,024




HUF


Hungarian forint


312,08




PLN


Polish zloty


4,2631




RON


Romanian leu


4,4467




TRY


Turkish lira


3,0865




AUD


Australian dollar


1,4689




CAD


Canadian dollar


1,4121




HKD


Hong Kong dollar


8,2001




NZD


New Zealand dollar


1,6189




SGD


Singapore dollar


1,4927




KRW


South Korean won


1 221,76




ZAR


South African rand


15,1490




CNY


Chinese yuan renminbi


6,7650




HRK


Croatian kuna


7,6230




IDR


Indonesian rupiah


14 628,60




MYR


Malaysian ringgit


4,5150




PHP


Philippine peso


49,921




RUB


Russian rouble


69,9945




THB


Thai baht


37,972




BRL


Brazilian real


3,9359




MXN


Mexican peso


17,5099




INR


Indian rupee


70,6449






(1)  Source: reference exchange rate published by the ECB.
Non-opposition to a notified concentration (Case M.7790 — Carrefour Group/Rue du Commerce) (Text with EEA relevance)
Date: 2015-11-28
Institutions: European Commission
Subjects: advertising, economic concentration, electronic commerce, food industry, merger control, supermarket, vehicle parts








C_2015397EN.01000102.xml










28.11.2015   


EN


Official Journal of the European Union


C 397/1





Non-opposition to a notified concentration
(Case M.7790 — Carrefour Group/Rue du Commerce)
(Text with EEA relevance)
(2015/C 397/02)
On 24 November 2015, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in French language and will be made public after it is cleared of any business secrets it may contain. It will be available:






—


in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,










—


in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32015M7790. EUR-Lex is the online access to the European law.






(1)  OJ L 24, 29.1.2004, p. 1.